1,000 Shares in Axon Enterprise, Inc $AXON Acquired by Anderson Financial Strategies LLC

Key Points

• Anderson Financial Strategies LLC acquired 1,000 shares of Axon Enterprise, Inc for approximately $526,000 in the first quarter, indicating growing interest from institutional investors.
• Axon reported $2.12 earnings per share for the recent quarter, exceeding analysts' estimates and marking a 32.6% year-over-year revenue growth.
• Analysts have set a consensus price target of $837.69 for Axon, with ratings suggesting a strong outlook for the company's stock.

Anderson Financial Strategies LLC purchased a new position in Axon Enterprise, Inc (NASDAQ:AXON - Free Report) during the 1st quarter, according to the company in its most recent Form 13F filing with the SEC. The firm purchased 1,000 shares of the biotechnology company's stock, valued at approximately $526,000.

Several other hedge funds have also made changes to their positions in AXON. GAMMA Investing LLC lifted its holdings in shares of Axon Enterprise by 58,725.5% in the 1st quarter. GAMMA Investing LLC now owns 764,731 shares of the biotechnology company's stock worth $402,210,000 after purchasing an additional 763,431 shares during the last quarter. Jennison Associates LLC raised its holdings in shares of Axon Enterprise by 23,203.7% during the first quarter. Jennison Associates LLC now owns 614,053 shares of the biotechnology company's stock valued at $322,961,000 after buying an additional 611,418 shares during the last quarter. Nuveen LLC bought a new stake in shares of Axon Enterprise during the first quarter valued at approximately $264,796,000. Westfield Capital Management Co. LP raised its holdings in shares of Axon Enterprise by 29.8% during the first quarter. Westfield Capital Management Co. LP now owns 927,801 shares of the biotechnology company's stock valued at $487,977,000 after buying an additional 212,931 shares during the last quarter. Finally, Vanguard Group Inc. raised its stake in Axon Enterprise by 2.2% during the 1st quarter. Vanguard Group Inc. now owns 8,632,008 shares of the biotechnology company's stock valued at $4,540,005,000 after acquiring an additional 185,571 shares in the last quarter. Institutional investors own 79.08% of the company's stock.

Axon Enterprise Stock Performance

Shares of AXON stock opened at $747.55 on Thursday. Axon Enterprise, Inc has a 1-year low of $353.91 and a 1-year high of $885.91. The company has a current ratio of 2.95, a quick ratio of 2.71 and a debt-to-equity ratio of 0.63. The company has a market capitalization of $58.68 billion, a price-to-earnings ratio of 184.58, a P/E/G ratio of 26.87 and a beta of 1.40. The stock's fifty day simple moving average is $762.78 and its 200-day simple moving average is $682.93.

Axon Enterprise (NASDAQ:AXON - Get Free Report) last issued its quarterly earnings results on Monday, August 4th. The biotechnology company reported $2.12 earnings per share for the quarter, beating analysts' consensus estimates of $1.54 by $0.58. Axon Enterprise had a return on equity of 6.80% and a net margin of 13.64%.The business had revenue of $668.54 million for the quarter, compared to the consensus estimate of $641.77 million. During the same quarter in the previous year, the company posted $1.20 earnings per share. Axon Enterprise's revenue for the quarter was up 32.6% compared to the same quarter last year. Axon Enterprise has set its FY 2025 guidance at EPS. On average, sell-side analysts predict that Axon Enterprise, Inc will post 5.8 earnings per share for the current fiscal year.

Insider Buying and Selling at Axon Enterprise

In other Axon Enterprise news, CEO Patrick W. Smith sold 10,000 shares of Axon Enterprise stock in a transaction on Monday, September 8th. The shares were sold at an average price of $743.64, for a total transaction of $7,436,400.00. Following the completion of the sale, the chief executive officer owned 3,043,982 shares of the company's stock, valued at $2,263,626,774.48. This trade represents a 0.33% decrease in their position. The sale was disclosed in a filing with the SEC, which is available at this hyperlink. Also, President Joshua Isner sold 15,919 shares of Axon Enterprise stock in a transaction on Friday, August 15th. The shares were sold at an average price of $746.26, for a total transaction of $11,879,712.94. Following the sale, the president directly owned 238,379 shares of the company's stock, valued at $177,892,712.54. This trade represents a 6.26% decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 44,865 shares of company stock valued at $34,362,833 in the last ninety days. Company insiders own 4.40% of the company's stock.

Analysts Set New Price Targets

Several analysts have weighed in on the company. Morgan Stanley set a $885.00 target price on Axon Enterprise and gave the company an "overweight" rating in a research note on Friday, July 11th. Raymond James Financial reissued an "outperform" rating and issued a $855.00 price objective (up previously from $645.00) on shares of Axon Enterprise in a research note on Tuesday, August 5th. Wolfe Research initiated coverage on Axon Enterprise in a research note on Monday, July 7th. They issued an "outperform" rating on the stock. Northland Securities set a $800.00 price objective on Axon Enterprise in a research note on Tuesday, August 5th. Finally, Bank of America boosted their price objective on Axon Enterprise from $895.00 to $1,000.00 and gave the stock a "buy" rating in a research note on Wednesday, August 6th. Thirteen investment analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company. According to MarketBeat.com, the company presently has an average rating of "Moderate Buy" and a consensus price target of $837.69.

Axon Enterprise Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.

Want to see what other hedge funds are holding AXON? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Axon Enterprise, Inc (NASDAQ:AXON - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.